Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barre syndrome and fisher's syndrome

Annals of Neurology

Volumn 42, Issue 1, 1997, Pages 28-33

  Yuki, Nobuhiro ^a,e   Takahashi, Masaki ^b   Tagawa, Yumi ^c   Kashiwase, Kouichi ^d   Tadokoro, Kenji ^d   Saito, Kahiko ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^e DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CAMPYLOBACTER JEJUNI; ENTERITIS; GUILLAIN BARRE SYNDROME; HLA SYSTEM; HUMAN; PRIORITY JOURNAL; SEROTYPE; SUBCLAVIAN STEAL SYNDROME;

ANTIBODIES; ATAXIA; CAMPYLOBACTER JEJUNI; GANGLIOSIDES; HLA ANTIGENS; HUMANS; OPHTHALMOPLEGIA; POLYNEUROPATHIES; POLYRADICULONEUROPATHY; REFLEX, ABNORMAL; SEROTYPING; SYNDROME;

EID: 0030795674     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420107     Document Type: Article

References (28)

1. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-1379
2. Lior H, Woodward DL, Edgar JA, et al. Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile anti-genic factors. J Clin Microbiol 1982;15:761-768
3. Penner JL, Hennessy JN. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol 1980;12:732-737
4. Kuroki S, Saida T, Nukina M, et al. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann Neurol 1993;33:243-247
5. Enders U, Karch H, Toyka KV, et al. Campylobacter jejuni and Guillain-Barré syndrome. Ann Neurol 1994;35:249 (Reply to letter)
6. Sachs JJ, Lieb S, Baldy LM, et al. Epidemic campylobacteriosis associated with a community water supply. Am J Public Health 1986;76:424-429
7. Yuki N, Sato S, Itoh T, Miyatake T. HLA-B35 and acute axonal polyneuropathy following Campylobacter infection. Neurology 1991;41:1561-1563
8. Rees JH, Vaughan RW, Kondeatis E, Hughes RAC. HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J Neuroimmunol 1995;62:53-57
9. Visser LH, van der Meché FGA, van Doom PA, et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 1995;118:841-847
10. Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816
11. Hayashi H, Park-Matsumoto Y-C, Yuki N, et al. A case of recurrent Guillain-Barré syndrome preceded by different infections. J Neurol 1993;240:196-197 (Letter)
12. Yuki N, Sato S, Yoshino H, Miyatake T. Axonal Guillain-Barré. Neurology 1991;41:1530-1531 (Reply to letter)
13. Kusunoki S, Chiba A, Kon K, et al. N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 1994;35:570-576
14. Yuki N, Taki T, Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neuroimmunol 1996;71:155-161
15. Yuki N, Sato S, Fujimoto S, et al. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome. Muscle Nerve 1992;15:968-969 (Letter)
16. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):S21-S24
17. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: FA Davis, 1991:18-21
18. Kawai S, Maekawajiri S, Tokunaga K, et al. A simple method of HLA-DRB typing using enzymatically amplified DNA and immobilized probes on microtiter plate. Hum Immunol 1994; 41:121-126
19. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Arm Neurol 1996;36:668-672
20. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902
21. Yuki N, Miyatani N, Sato S, et al. Acute relapsing sensory neuropathy associated with IgM antibody against B-series gangliosides containing a GalNAc β1-4 Gal(3-2α NeuAc 8-2α NeuAc)β1 configuration. Neurology 1992;42:686-689
22. Aspinall GO, McDonald AG, Raju TS, et al. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur J Biochem 1993; 213:1017-1027
23. Yuki N, Taki T, Takahashi M, et al. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears GD1a epitope. Infect Immun 1994;62:2101-2103
24. Yuki N, Handa S, Tai T, et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J Neurol Sci 1995;130:112-116
25. Aspinall GO, McDonald AG, Pang H, et al. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with Guillain-Barré syndrome. Biochemistry 1994;33:241-249
26. Aspinall GO, McDonald AG, Pang H. Lipopolysaccharides of Campylobacter jejuni serotype 0:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 1994;33: 250-255
27. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-1775
28. Yuki N, Taki T, Takahashi M, et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994;36:791-793